Raman spectroscopy (RS) has been widely used in a variety of biomedical applications. Nevertheless, there have been multiple technological and regulatory hurdles to move RS from the research lab to the bedside. From the regulatory point of view, especially in Europe, the new EU regulation on medical devices (Medical Device Regulation, MDR2017/745) complicates the translation. From the technical point of view the lack of imaging capabilities for fiber-optic Raman probes, the lack of depth information and the low imaging speed create challenges. Here, we present some of our recent developments to address current challenges.
|